Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Molecules ; 26(5)2021 Mar 05.
Article in English | MEDLINE | ID: mdl-33807712

ABSTRACT

BACKGROUND: Tart cherries (Prunus cerasus L.) are a rich source of anthocyanins. They are phytochemical flavonoids found in red and blue fruits, and vegetables that can reduce hyperlipidemia. Visceral Adipose Tissue (VAT) has emerged as a major player in driving obesity-related inflammatory response. METHODS: This study has investigated the potential positive effects of tart cherries on rats with Diet-Induced Obesity (DIO). In particular, the inflammatory status in retroperitoneal (RPW) and perigonadal (PGW) adipose tissue were studied. Rats were fed ad libitum for 17 weeks with a hypercaloric diet with the supplementation of tart cherries seeds powder (DS) and seeds powder plus tart cherries juice containing 1mg of anthocyanins (DJS). In RPW and PGW, expression of CRP, IL-1 ß, TNF-α, CCL2 and CD36, were measured by qRT-PCR, Western blot and immunohistochemistry techniques. RESULTS: No differences in the weight of RPW and PGW animals were found between DS and DJS groups compared to DIO rats. However, an increase of inflammatory markers was observed in DIO group in comparison with control lean rats. A modulation of these markers was evident upon tart cherry supplementation. CONCLUSION: Study results suggest that tart cherry enriched-diet did not modify the accumulation of visceral fat, but it decreased inflammatory markers in both tissues. Therefore, this supplementation could be useful, in combination with healthy lifestyles, to modify adipose tissue cell metabolism limiting-obesity related organ damage.


Subject(s)
Biomarkers/metabolism , Fruit and Vegetable Juices , Intra-Abdominal Fat/metabolism , Obesity/diet therapy , Prunus avium/chemistry , Animals , CD36 Antigens/genetics , CD36 Antigens/metabolism , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Diet, High-Fat/adverse effects , Dietary Supplements , Gene Expression Regulation , Intra-Abdominal Fat/drug effects , Macrophages/drug effects , Macrophages/pathology , Male , Obesity/etiology , Panniculitis/diet therapy , Panniculitis/genetics , Panniculitis/metabolism , Rats, Wistar , Seeds
2.
Eur J Nutr ; 60(5): 2695-2707, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33386893

ABSTRACT

PURPOSE: There is increasing evidence for the involvement of dietary bioactive compounds in the cross-talk modulation of endocannabinoid system and some of the key regulators of transcriptional control for adipogenesis. METHODS: We aimed to characterize the expression of cannabinoid CB1/CB2 receptors and fatty acid amide hydrolase (FAAH) along with selected adipogenesis-related genes (PPARγ, SREBP-1c and PREF-1), adipocyte-secreted factors (leptin and adiponectin), mitochondrial bioenergetic modulators (PGC-1A and UCP-2), and transient receptor potential vanilloid subtype 1 (TRPV1) and 2 (TRPV2) channels in visceral adipose tissue of rats fed with a high-fat diet (HFD) containing either tart cherry seeds alone or tart cherry seeds and juice for 17 weeks. The visceral adipose tissue was weighed and checked the expression of different markers by qRT-PCR, Western blot and immunohistochemistry. RESULTS: Tart cherry supplements were able to downregulate the HFD-induced mRNA expression of CB1 receptor, SREBP-1c, PPARγ, leptin, TRPV1 and TRPV2 resulting in potential anti-adipogenic effects. CONCLUSION: The present study points out that the intake of bioactive constituents of tart cherry may attenuate the effect of adipogenesis by acting directly on the adipose tissue and modulating the interplay between CB1, PPARγ and TRPV channel gene transcription.


Subject(s)
Prunus avium , Adipogenesis , Adipose Tissue , Animals , Diet, High-Fat/adverse effects , Dietary Supplements , Intra-Abdominal Fat , Obesity/genetics , RNA, Messenger/genetics , Rats
3.
Nutrients ; 12(5)2020 May 04.
Article in English | MEDLINE | ID: mdl-32375317

ABSTRACT

The accumulation of adipose tissue increases the risk of several diseases. The fruits-intake, containing phytochemicals, is inversely correlated with their development. This study evaluated the effects of anthocyanin-rich tart cherries in diet-induced obese (DIO) rats. DIO rats were exposed to a high-fat diet with the supplementation of tart cherry seeds powder (DS) and seed powder plus juice (DJS). After 17 weeks, the DIO rats showed an increase of body weight, glycaemia, insulin, and systolic blood pressure. In the DS and DJS groups, there was a decrease of systolic blood pressure, glycaemia, triglycerides, and thiobarbituric reactive substances in the serum. In the DJS rats, computed tomography revealed a decrease in the spleen-to-liver attenuation ratio. Indeed, sections of the DIO rats presented hepatic injury characterized by steatosis, which was lower in the supplemented groups. In the liver of the DIO compared with rats fed with a standard diet (CHOW), a down-regulation of the GRP94 protein expression and a reduction of LC3- II/LC3-I ratio were found, indicating endoplasmic reticulum stress and impaired autophagy flux. Interestingly, tart cherry supplementation enhanced both unfolded protein response (UPR) and autophagy. This study suggests that tart cherry supplementation, although it did not reduce body weight in the DIO rats, prevented its related risk factors and liver steatosis.


Subject(s)
Anthocyanins/administration & dosage , Diet, High-Fat/adverse effects , Dietary Supplements , Fatty Liver/etiology , Fatty Liver/prevention & control , Fruit and Vegetable Juices , Obesity/etiology , Obesity/metabolism , Phytochemicals/administration & dosage , Phytotherapy , Prunus avium , Seeds , Animals , Autophagy , Body Weight , Disease Models, Animal , Down-Regulation , Endoplasmic Reticulum Stress , Fatty Liver/metabolism , Gene Expression , Male , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Protein Folding , Rats, Wistar
4.
Nutrients ; 9(10)2017 Sep 29.
Article in English | MEDLINE | ID: mdl-28961195

ABSTRACT

Choline is involved in relevant neurochemical processes. In particular, it is the precursor and metabolite of acetylcholine (ACh). Choline is an essential component of different membrane phospholipids that are involved in intraneuronal signal transduction. On the other hand, cholinergic precursors are involved in ACh release and carry out a neuroprotective effect based on an anti-inflammatory action. Based on these findings, the present study was designed to evaluate the effects of choline and choline precursor (Choline alphoscerate, GPC) in the modulation of inflammatory processes in the rat brain. Male Wistar rats were intraperitoneally treated with 87 mg of choline chloride/kg/day (65 mg/kg/day of choline), and at choline-equivalent doses of GPC (150 mg/kg/day) and vehicle for two weeks. The brains were dissected and used for immunochemical and immunohistochemical analysis. Inflammatory cytokines (Interleukin-1ß, IL-1ß; Interleukin-6 , IL-6 and Tumor Necrosis Factor-α, TNF-α) and endothelial adhesion molecules (Intercellular Adhesion Molecule, ICAM-1 and Vascular cell Adhesion Molecule, VCAM-1) were studied in the frontal cortex, hippocampus, and cerebellum. The results clearly demonstrated that treatment with choline or GPC did not affect the expression of the inflammatory markers in the different cerebral areas evaluated. Therefore, choline and GPC did not stimulate the inflammatory processes that we assessed in this study.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cerebral Cortex/drug effects , Choline/therapeutic use , Encephalitis/prevention & control , Glycerylphosphorylcholine/therapeutic use , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Biomarkers/metabolism , Cerebellum/drug effects , Cerebellum/immunology , Cerebellum/metabolism , Cerebellum/pathology , Cerebral Cortex/immunology , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Choline/administration & dosage , Choline/adverse effects , Cytokines/metabolism , Encephalitis/immunology , Encephalitis/metabolism , Encephalitis/pathology , Frontal Lobe/drug effects , Frontal Lobe/immunology , Frontal Lobe/metabolism , Frontal Lobe/pathology , Glycerylphosphorylcholine/administration & dosage , Glycerylphosphorylcholine/adverse effects , Hippocampus/drug effects , Hippocampus/immunology , Hippocampus/metabolism , Hippocampus/pathology , Injections, Intraperitoneal , Intercellular Adhesion Molecule-1/metabolism , Male , Nerve Tissue Proteins/metabolism , Neurons/immunology , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/adverse effects , Neuroprotective Agents/cerebrospinal fluid , Rats, Wistar , Vascular Cell Adhesion Molecule-1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL